Showing results (121-130 of 202) with videos related to

Sort By:
Pageof 21
Cancer Chemotherapy and Pharmacology|April 2, 2008
Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumabE Montagna, G Cancello, D D'Agostino, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Antiemetic activity of the new 5-HT3 antagonist DAU 6215 in animal models of cancer chemotherapy and radiationA Sagrada, M Turconi, P Bonali, et al.
Anticancer Research|March 26, 2002
Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: a promising low-toxic regimenL Orlando, M Colleoni, G Curigliano, et al.
British Journal of Cancer|October 23, 2008
Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activityR Torrisi, V Bagnardi, A Cardillo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2005
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effectsM Colleoni, L Orlando, G Sanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: an active and well-tolerated regimenM Colleoni, G Martinelli, F Beretta, et al.
Annals of Surgical Oncology|May 22, 2020
Contralateral Axillary Lymph Node Metastases from Breast Carcinoma: Is it Time to Review TNM Cancer Staging?Francesca Magnoni, M Colleoni, D Mattar, et al.
British Journal of Cancer|August 23, 2007
Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancerR Torrisi, V Bagnardi, G Pruneri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptorsM Colleoni, I Minchella, G Mazzarol, et al.
Breast Cancer Research and Treatment|April 3, 2012
Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancerElisabetta Munzone, E Botteri, A Sciandivasci, et al.
Pageof 21